Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease

Sci Rep. 2025 Aug 14;15(1):29798. doi: 10.1038/s41598-025-14993-y.

Abstract

The aim of this case-control study was to evaluate the ability of digital health technology (DHT) to detect and quantify mobility alterations in late-onset Pompe Disease. The study enrolled eight subjects with Pompe Disease, including three young mildly affected/asymptomatic subjects, who underwent an extensive DHT mobility assessment and were contrasted to 52 matched controls. DHT enabled the detection of subtle mobility alterations, indicating a lower speed in walking, and worse performances in postural transition and turning in patients compared to controls. Interestingly, in the three mildly affected/asymptomatic cases, step time variability and step length showed detectable alterations compared to controls, despite scores within the normal range on clinical scales and timed tests.

Keywords: Digital health technology; Digital technology; Mobility; Pompe disease; Progression.

MeSH terms

  • Adult
  • Case-Control Studies
  • Digital Technology*
  • Female
  • Glycogen Storage Disease Type II* / diagnosis
  • Glycogen Storage Disease Type II* / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Walking / physiology